Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The smartphone app is designed to be used alongside existing treatments and is currently being deployed within select NHS Trusts, with broader uptake anticipated over the coming year. Rejoyn delivers a six-week cognitive training programme that […]
The post Smartphone app for treating depression launches in UK appeared first on Pharmafile.
